Clinicopathological Conference, Systemic Lupus Erythematosus with Antiphospholipid Syndrome
NEJM 386:1560-1570, Case 12-2022, 2022
Diagnosis and Management of the Antiphospholipid Syndrome
NEJM 378:2010-2021, Garcia, D. & Erkan, D., 2018
Lambls Excrescense Associated with Cryptogenic Stroke
Am J Case Rep 16:876-881, Chu, A.,et al, 2015
Retrospective Review of Cerebral Mycotic Aneurysms in 26 Patients: Focus on Treatment in Strongly Immunocompromised Patients with a Brief Literature Review
AJNR 34:823-827, Allen, L.M.,et al, 2013
Cerebral Ischemic Events After Diagnosis of Mitral Valve Prolapse
Stroke 34:1339-1345, Avierinos,J.,et al, 2003
Cerebral Ischemic Events Associated with Endocarditis, Retinal Vascular Disease, & Lupus Anticoagulant
Am J Med 90:299-309, Pope,J.M.,et al, 1991
Cerebrovascular Disease & Antiphospholipis Antibodies in SLE, Lupus-Like Dis, & Primary Antiphospholipid Synd
Am J Med 86:391-399, Asherson,R.A.,et al, 1989
Cardiogenic Brain Embolism and Lupus Anticoagulants
Ann Neurol 26:390-392, Young,S.M.,et al, 1989
Antiphospholipid Antibodies
Ann Neurol 26:386-389, Levine,S.R.&Welch,K.M.A., 1989
Clinicopath Conf
Antiphospholipid-Antibody Syndrome, ANA-Negative Systemic Lupus Erythematosus, Case Study 37-1988, N, JM :699-712,1988., 1988
Epidemiologic Assessment of Chronic Atrial Fibrillation & Risk of Stroke:The Framingham Study
Neurol 28:973-977, Wolf,P.A.,et al, 1978
Neuro CPC of MGH
Cerebral Embolism & Infarction, NEJM 267:1084-109162., , 1962